After Covaxin and Covishield, the Union Health Ministry also approved Corbevax as a booster dose against Covid-19. Biological E's Corbevax is allowed for double-vaccinated people above 18-years-old. The recommendations were given by the National Technical Advisory Group on Immunisation (NTAG). Corbevax, considered a precaution dose will be given six months or 26 weeks from the date of the second dose of either Covaxin/Covisheild. Necessary… read-more
The Covid-19 vaccine Corbevax, manufactured by BiologicalE in Hyderabad, is the first to be licensed as a heterologous booster in adults by Drugs Controller General of India. Individuals who had Covishield/Covaxin for their first two doses can get Corbevax as their third. Following the booster dosage of Corbevax, neutralizing antibodies against Omicron variation were identified in 91% of individuals who had received Covishield and in 75% who… read-more
Courtesy: The Indian Express
The Haryana government has rolled out "free" booster doses for the 18-59 age group. The announcement came just days after the Delhi government made booster shots freely available for the age group. Around a whopping Rs 300 crores of taxpayers' money out of the state Covid-19 Relief Fund would be dedicated to this program. Experts are divided on the need for these "precautionary" doses.
Courtesy: Zee News
The Serum Institute of India has halted the production of the Covishield (AstraZeneca) vaccine amid a glut of vaccine supplies. The SII's stockpile of vaccines has swelled to 200 million doses. The export of Covid vaccines had been earlier restricted, but resumed in November last year. The SII had recently appealed to the government to cut the gap between the second dose and the "precautionary" dose to just six months.
The Kerala HC has sought the Centre's response over a plea regarding a post-Covid-19 vaccination death. The post-mortem report of the deceased confirmed that death was due to intracranial bleeding. The Medical officer suspects that it was a case of thrombosis-with-thrombocytopenia-syndrome (TTS), a rare but well-known adverse event associated with the adenovirus vector-based Covishield vaccine. The plea argues that the victim had not been… read-more
Courtesy: Live Law
Parents of a post-graduate student in Kerala demanded compensation of Rs 10 crore after their daughter died after taking the Covishield vaccine. They blamed the Central government, Serum Institute of India for the complications and filed a petition in the Kerala HC. "Nova Sabu might have suffered from thrombocytopenia, thrombosis syndrome, which is an immunogenic response to the Covishield vaccine, a rare condition due to Covidshield… read-more
Courtesy: India Today
Ahead of the nationwide booster dose COVID-19 vaccination drives, the SII CEO Adar Poonawalla slashed the prices of Covishield from Rs 600 to Rs 225. On April 9, Poonawalla tweeted, "SII has decided to revise the price of COVISHIELD vaccine for private hospitals from Rs.600 to Rs 225 per dose". Notably, the GoI announced a booster dose for the 18+ population at private vaccination centers in India from… read-more
National Technical Advisory Group on Immunisation (NTAGI) suggested reduction of gap between two doses of Covishield. Notably, acting upon the suggestion, the Central Government is likely to reduce the gap, as Covid-19 cases are rising in different nations, including China. The panel suggested to reduce gap to eight-twelve weeks, from previous 16-12 weeks, for Covishield. Furthermore, the Government is also planning to reduce age… read-more
The Drugs Controller General of India (DCGI) on January 27, granted regular market approval to India's Covaxin and Covishield vaccines against COVID-19. Following SEC's recommendations, the DCGI allowed only hospitals and clinics to purchase the SII's Covishield and Bharat Biotech's Covaxin under the New Drugs And Clinical Trials 2019 Act. However, the authority needs to submit data every six months to the DCGI and update on CoWIN app.
Courtesy: News 18
Andaman & Nicobar Island becomes first in India to achieve 100 % vaccination, under the "nationwide vaccination drive". The UT in a tweet said, "A&N achieved 100% COVID vaccine coverage making it first state/UT to achieve the feat using only Covishield. The UT Admin overcame Insurmountable odds for the extraordinary feat in one of the remotest parts of world." A total of 2.86 lakh people received both doses of vaccine.